Back

FCGR2A-131H/H is under-represented amongst patients with primary immunodeficiencies

Flewitt, E. W. D.; Charlesworth, J. E. G.; Patel, S. Y.; Hargreaves, C. E.

2023-10-13 allergy and immunology
10.1101/2023.10.12.23296440
Show abstract

The Fc{gamma} receptors (Fc{gamma}Rs) act as modulators of the immune system and have previously been shown to play a role in immune disorders such as systemic lupus erythematosus and immune thrombocytopenic purpura. Thus far, their role in primary immunodeficiencies (PID), including common variable immunodeficiency disorders (CVID), has not been studied. In this paper we explored whether there is an association between the following single nucleotide polymorphisms (SNPs) and CVID: FCGR2A H131R (rs1801274), FCGR2B I232T (rs1050501), and FCGR3A F158V (rs396991). We compared the genotypes of a cohort of 83 patients with PID, including 56 with CVID, against controls. We found a significant difference between our mixed PID cohort and controls at the FCGR2A H131R SNP (X2 =7.884, p=0.019). There was not a significant difference at either of the other SNPs studied. Further, we examined the effect of FCGR SNPs on the incidence of the most common CVID complications within our cohort: anaemias, organ-specific autoimmunity, bronchiectasis, splenomegaly, granulomata, and cytopenias. We found no significant association between SNPs and the development of these complications. In summary, we have shown that there is a link between the FCGR2A H131R SNP and the development of a PID.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
based on 140 papers
Top 0.1%
21.0%
2
PLOS ONE
based on 1737 papers
Top 47%
10.8%
3
Clinical Immunology
based on 12 papers
Top 0.1%
8.1%
4
Journal of Clinical Immunology
based on 11 papers
Top 0.1%
8.1%
5
Allergy
based on 13 papers
Top 0.4%
4.8%
50% of probability mass above
6
The Journal of Immunology
based on 19 papers
Top 0.4%
3.1%
7
Life Science Alliance
based on 11 papers
Top 0.1%
2.7%
8
Journal of Medical Virology
based on 95 papers
Top 3%
2.6%
9
Annals of the Rheumatic Diseases
based on 23 papers
Top 0.7%
2.6%
10
Clinical Infectious Diseases
based on 219 papers
Top 13%
1.9%
11
Cells
based on 14 papers
Top 0.6%
1.7%
12
Scientific Reports
based on 701 papers
Top 70%
1.7%
13
JCI Insight
based on 63 papers
Top 3%
1.7%
14
Vaccines
based on 131 papers
Top 4%
1.4%
15
Nature Immunology
based on 14 papers
Top 0.8%
1.4%
16
Journal of Experimental Medicine
based on 10 papers
Top 0.6%
1.3%
17
Clinical & Translational Immunology
based on 14 papers
Top 0.4%
1.3%
18
Science Immunology
based on 15 papers
Top 1%
0.8%
19
Journal of Clinical Investigation
based on 50 papers
Top 3%
0.8%
20
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 2%
0.8%
21
Frontiers in Medicine
based on 99 papers
Top 20%
0.7%
22
European Respiratory Journal
based on 44 papers
Top 6%
0.7%
23
Vaccine
based on 140 papers
Top 5%
0.7%
24
Biology
based on 11 papers
Top 1%
0.7%
25
Transfusion
based on 14 papers
Top 0.7%
0.7%
26
The Lancet Rheumatology
based on 11 papers
Top 0.9%
0.7%
27
Frontiers in Genetics
based on 32 papers
Top 6%
0.7%